1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FBXO5 CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA HNRNPH1 CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA MPHOSPH9 CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA MBD3 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA ZNF407 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA SRRT CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA BRD3 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA REXO2 CTRPv2 pan-cancer AAC -0.18 2e-08
mRNA CBX5 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA PSIP1 CTRPv2 pan-cancer AAC 0.18 2e-08
Download CSV